ELI LILLY (I8F-MC-GPGH)

By June 19, 2019 Active/Enrolling

A Randomized, Phase 3, Open-Label Trial Comparing the effect of LY3298176 versus Titrated Insulin Degludec on Glycemic Control in Patients with Type 2 Diabetes (SURPASS-3)

Leave a Reply